XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Incentive Plans (Tables)
3 Months Ended
Mar. 31, 2023
Nonvested Restricted Stock Shares Activity RSU activity for the three months ended March 31, 2023 was as follows:

 

 

 

Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Unvested at December 31, 2022

 

 

456,766

 

 

$

26.70

 

Granted

 

 

374,458

 

 

 

41.59

 

Vested and released

 

 

(45,206

)

 

 

24.58

 

Cancelled

 

 

(12,358

)

 

 

33.67

 

Unvested at March 31, 2023

 

 

773,660

 

 

$

33.92

 

Summary of Activity under Employee Stock Purchase Plan Activity under our 2020 ESPP was as follows:

 

 

 

Shares

 

Balance - December 31, 2021

 

 

1,070,704

 

Additional shares authorized

 

 

530,319

 

Shares purchased

 

 

(61,709

)

Balance - December 31, 2022

 

 

1,539,314

 

Additional shares authorized

 

 

794,706

 

Shares purchased

 

 

 

Balance - March 31, 2023

 

 

2,334,020

 

Summary of Estimated Fair Value of Employee Stock Options

We estimated the fair value of employee stock options using the Black-Scholes option-pricing model for the three months ended March 31, 2023 and 2022 using the following weighted-average assumptions:

 

 

Three Months Ended March 31,

 

 

 

2023

 

2022

 

Fair Value Assumptions

 

 

 

 

 

Expected volatility

 

73.6% - 74.0%

 

78.1% - 78.9%

 

Expected dividend yield

 

0%

 

0%

 

Expected term (in years)

 

5.3 - 5.4

 

5.4

 

Risk-free interest rate

 

3.7% - 4.3%

 

1.6% - 2.4%

 

2020 Plan and 2014 Plan  
Summary of Activity Under Stock Option Plans

Stock options and RSUs activity under our 2020 Plan and 2014 Plan, which excludes options to purchase 36,710 shares granted outside of the 2020 Plan and 2014 Plan, was as follows:

 

 

 

 

 

 

 

Options Outstanding

 

Stock Options and Restricted Stock Units Activity

 

Options and
Restricted Stock Units Available for Grant

 

 

 

Number
of
Options

 

 

Weighted-
Average
Exercise
Price Per
Share

 

 

Weighted-
Average
Remaining
Contractual
Term
(Years)

 

 

Aggregate
Intrinsic
Value

 

Balances — December 31, 2022

 

 

4,679,598

 

 

 

 

7,715,494

 

 

$

18.70

 

 

 

 

 

 

 

Additional shares authorized

 

 

3,973,533

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

(1,574,642

)

 

 

 

1,574,642

 

 

$

41.84

 

 

 

 

 

 

 

Options exercised

 

 

1,080

 

(1)

 

 

(102,044

)

 

$

5.40

 

 

 

 

 

 

 

Options forfeited

 

 

41,058

 

 

 

 

(41,058

)

 

$

31.95

 

 

 

 

 

 

 

Restricted stock units granted

 

 

(374,458

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock units withheld

 

 

17,525

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock units forfeited

 

 

12,358

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances — March 31, 2023

 

 

6,776,052

 

 

 

 

9,147,034

 

 

$

22.77

 

 

 

8.32

 

 

$

146,986

 

Vested and expected to vest — March 31, 2023

 

 

 

 

 

 

9,147,034

 

 

$

22.77

 

 

 

8.32

 

 

$

146,986

 

Exercisable at March 31, 2023

 

 

 

 

 

 

3,242,028

 

 

$

10.88

 

 

 

6.85

 

 

$

86,670

 

 

(1)
Net exercise – shares returned to the Plan.
2020 Employee Stock Purchase Plan  
Summary of Estimated Fair Value of Shares Under Employee Stock Purchase Plan

We estimated the fair value of shares under the 2020 ESPP using the Black-Scholes option-pricing model for the three months ended March 31, 2023 and 2022 using the following weighted-average assumptions:

 

 

 

Three Months Ended March 31,

 

 

 

2023

 

2022

 

Fair Value Assumptions

 

 

 

 

 

Expected volatility

 

86.4% - 99.7%

 

86.7% - 97.5%

 

Expected dividend yield

 

0%

 

0%

 

Expected term (in years)

 

0.5 - 2.0

 

0.5 - 2.0

 

Risk-free interest rate

 

4.5% - 4.7%

 

0.1% - 0.5%

 

2014 Plan, 2020 Plan and 2020 ESPP  
Summary of Stock-based Compensation Expense

We recorded total stock-based compensation expense for the three months ended March 31, 2023 and 2022 related to the 2014 Plan, the 2020 Plan and the 2020 ESPP in the condensed statements of operations and allocated the amounts as follows:

 

 

Three Months Ended March 31,

 

 

 

 

2023

 

 

2022

 

 

 

 

(in thousands)

 

 

Research and development

 

$

4,527

 

 

$

1,775

 

 

General and administrative

 

 

5,121

 

 

 

2,324

 

 

Total

 

$

9,648

 

 

$

4,099